F. Stephen Hodi,Jun Zhou,Gordon J. Freeman,Jingjing Li,Xinqi Wu
申请号:
US16365978
公开号:
US20190375818A1
申请日:
2019.03.27
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention relates to compositions and methods for identifying, assessing, preventing, and treating melanoma. A variety of PD-L1 isoform biomarkers are provided, wherein alterations in the copy number of one or more of the biomarkers and/or alterations in the amount, structure, and/or activity of one or more of the biomarkers is associated with melanoma status.